Raynaud’s is either primary (idiopathic) or secondary. Secondary is especially common in connective tissue diseases. This session will discuss how to differentiate primary from secondary and tips for determining which patients may have a CTD in the future, especially systemic sclerosis. Appropriate investigations for patients with Raynaud’s will be provided. Evidence based treatment for Raynaud’s and digital ulcers will be presented including recent data from RCTs. This knowledge will assist clinicians in appropriate work up, diagnosis and treatment of primary and secondary RP as well as complications of RP.
Upon completion of this session, participants should be able to:
- discuss the etiology of Raynaud’s and differentiate Raynaud’s from mimickers
- describe the appropriate investigations for Raynaud's phenomenon and be aware of those patients at risk for the development of a connective tissue disease
- review treatment options for Raynaud’s, threatened digital ischemia and digital ulcers that are evidence based including new data from recent trials
To see other sessions for this day, use the date buttons to the left.